Smink, J. J., & Leutz, A. (2009). Rapamycin and the transcription factor C/EBPβ as a switch in osteoclast differentiation: Implications for lytic bone diseases. Springer-Verlag.
Chicago Style CitationSmink, Jeske J., i Achim Leutz. Rapamycin and the Transcription Factor C/EBPβ As a Switch in Osteoclast Differentiation: Implications for Lytic Bone Diseases. Springer-Verlag, 2009.
Cita MLASmink, Jeske J., i Achim Leutz. Rapamycin and the Transcription Factor C/EBPβ As a Switch in Osteoclast Differentiation: Implications for Lytic Bone Diseases. Springer-Verlag, 2009.
Atenció: Aquestes cites poden no estar 100% correctes.